CAS: 1005264-47-0
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
MX-69 REF: IN-DA0096EHCAS: 1005264-47-0 | % | To inquire | Tue 21 Jan 25 | |
MX-69 REF: 3B-M3570CAS: 1005264-47-0 | >98.0%(T)(HPLC) | 154.00 € | Thu 23 Jan 25 | |
MX69 REF: TM-T3653CAS: 1005264-47-0 | 97.27% - 99.57% | 36.00 €~1,170.00 € | Mon 27 Jan 25 | |
MX69 REF: 3D-FQB26447CAS: 1005264-47-0 | Min. 95% | To inquire | Mon 03 Mar 25 |
Ref: IN-DA0096EH
10mg | 326.00 € | ||
25mg | 110.00 € | ||
50mg | 189.00 € | ||
100mg | 207.00 € |
Estimated delivery in United States, on Tuesday 21 Jan 2025
MX-69
CAS:1005264-47-0
Formula:
C27H26N2O4S
Purity:
>98.0%(T)(HPLC)
Color and Shape:
White to Light yellow powder to crystal
Molecular weight:
474.58
Ref: 3B-M3570
25mg | 154.00 € |
Estimated delivery in United States, on Thursday 23 Jan 2025
MX69
CAS:1005264-47-0
MX69 is the MDM2/XIAP inhibitor, blocking the MDM2 protein-XIAP RNA interaction, leading to MDM2 degradation.
Formula:
C27H26N2O4S
Purity:
97.27% - 99.57%
Color and Shape:
Solid
Molecular weight:
474.57
Ref: TM-T3653
1mg | 36.00 € | ||
2mg | 52.00 € | ||
5mg | 78.00 € | ||
10mg | 119.00 € | ||
25mg | 225.00 € | ||
50mg | 363.00 € | ||
100mg | 541.00 € | ||
500mg | 1,170.00 € | ||
1mL*10mM (DMSO) | 82.00 € |
Estimated delivery in United States, on Monday 27 Jan 2025
MX69
CAS:1005264-47-0
MX69 is a compound that inhibits the BCL-2 protein. It was developed as an anti-cancer …
Formula:
C27H26N2O4S
Purity:
Min. 95%
Molecular weight:
474.57 g/mol
Ref: 3D-FQB26447
25mg | 798.00 € | ||
50mg | 1,200.00 € | ||
100mg | 1,670.00 € |
Estimated delivery in United States, on Monday 3 Mar 2025